Rex Remedies Distributors Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 25-07-2024
- Paid Up Capital ₹ 0.10 M
as on 25-07-2024
- Company Age 7 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 62.95%
(FY 2023)
- Ebitda 32.65%
(FY 2023)
- Net Worth -59.23%
(FY 2023)
- Total Assets -70.70%
(FY 2023)
About Rex Remedies Distributors
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Hussain, Kali Khandelwal, Saroj Khandelwal, and Four other members serve as directors at the Company.
- CIN/LLPIN
U74999RJ2017PTC058886
- Company No.
058886
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Aug 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Ajmer, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rex Remedies Distributors?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hussain  | Additional Director | Current | |
| Kali Khandelwal | Director | 27-Feb-2018 | Current |
| Saroj Khandelwal | Director | 27-Feb-2018 | Current |
| Madhav Khandelwal | Director | 24-Aug-2017 | Current |
| Narendra Khandelwal | Director | 24-Aug-2017 | Current |
| Kishan Khandelwal | Director | 27-Feb-2018 | Current |
Financial Performance of Rex Remedies Distributors.
Rex Remedies Distributors Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 62.95% increase in profit. The company's net worth observed a substantial decline by a decrease of 59.23%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rex Remedies Distributors?
In 2023, Rex Remedies Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Rasik Remedies Private LimitedActive 15 years 5 months
Kali Khandelwal, Saroj Khandelwal and 1 more are mutual person
- Agrodaya Products Private LimitedActive 5 years 7 months
Madhav Khandelwal and Vaibhav Khandelwal are mutual person
- V Care Remedies Private LimitedActive 10 years 2 months
Kishan Khandelwal and Vaibhav Khandelwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rex Remedies Distributors?
Unlock and access historical data on people associated with Rex Remedies Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rex Remedies Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rex Remedies Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
